Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Oct 31, 2025 | (Q2)Jul 31, 2025 | (Q1)Apr 30, 2025 | (FY)Jan 31, 2025 | (Q4)Jan 31, 2025 | (Q3)Oct 31, 2024 | (Q2)Jul 31, 2024 | (Q1)Apr 30, 2024 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -10.02%65.19M | -2.88%69.89M | -7.97%63.71M | -2.89%287.03M | -5.08%73.5M | -6.02%72.45M | 4.44%71.96M | -4.04%69.23M | 15.99%295.57M | 12.15%77.44M |
| Cost of revenue | -13.77%56.07M | -10.52%56.48M | -8.91%55.22M | -3.89%249M | -11.60%60.32M | -2.79%65.03M | 4.15%63.12M | -4.29%60.62M | 18.73%259.08M | 14.68%68.24M |
| Gross profit | 22.86%9.12M | 51.69%13.41M | -1.36%8.49M | 4.24%38.03M | 43.26%13.18M | -27.19%7.42M | 6.56%8.84M | -2.22%8.61M | -0.35%36.49M | -3.63%9.2M |
| Operating expense | 45.79%8.1M | 14.24%8.14M | 10.91%7.98M | 0.07%24.77M | 24.69%8.97M | -24.48%5.56M | -1.89%7.13M | 0.28%7.2M | -4.90%24.76M | 73.91%7.2M |
| Selling and administrative expenses | ---- | ---- | ---- | -0.24%28.84M | ---- | ---- | ---- | ---- | 0.20%28.91M | ---- |
| -Selling and marketing expense | ---- | ---- | ---- | 14.89%672.19K | ---- | ---- | ---- | ---- | -3.44%585.07K | ---- |
| -General and administrative expense | ---- | ---- | ---- | -0.55%28.17M | ---- | ---- | ---- | ---- | 0.28%28.32M | ---- |
| Other operating expenses | 45.79%8.1M | 14.24%8.14M | 10.91%7.98M | -28.96%62.33K | 24.69%8.97M | -24.48%5.56M | -1.89%7.13M | 0.28%7.2M | -16.02%87.75K | 133.03%7.2M |
| Total other operating income | ---- | ---- | ---- | -2.62%4.13M | ---- | ---- | ---- | ---- | 45.03%4.24M | ---- |
| Operating profit | -45.62%1.01M | 207.54%5.27M | -63.97%508K | 13.04%13.26M | 109.93%4.21M | -34.24%1.86M | 66.05%1.71M | -13.23%1.41M | 10.85%11.73M | -62.95%2M |
| Net non-operating interest income (expenses) | -20.70%-758K | -29.51%-847K | -6.79%-755K | -9.08%-2.46M | 16.99%-552K | 0.63%-628K | -20.89%-654K | -37.28%-707K | -9.99%-2.26M | -35.44%-665K |
| Non-operating interest income | ---- | ---- | ---- | -21.52%75.36K | ---- | ---- | ---- | ---- | --96.03K | ---- |
| Non-operating interest expense | 20.70%758K | 29.51%847K | 6.79%755K | 8.93%2.4M | -16.99%552K | -0.63%628K | 20.89%654K | 37.28%707K | 16.62%2.21M | 101.22%665K |
| Total other finance cost | ---- | ---- | ---- | -8.53%134.57K | ---- | ---- | ---- | ---- | -8.33%147.13K | ---- |
| Net investment income | 687.42%71.69K | -98.28%9.1K | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 78.69%713.88K | 76.22%399.51K | ||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 43K | 0 | ||||||||
| Less:Other special charges | ---- | ---- | ---- | ---43K | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | -24.57%1.36M | -42.80%910K | -5.11%2.03M | 11.16%1.9M | -35.84%1.41M | 14.81%1.8M | 7.21%1.59M | 76.74%2.14M | -16.62%1.71M | 203.77%2.2M |
| Income before tax | -46.87%1.61M | 101.13%5.33M | -37.32%1.78M | 16.70%13.53M | 43.25%5.06M | -19.47%3.03M | 34.19%2.65M | 22.43%2.84M | -13.52%11.59M | -37.17%3.54M |
| Income tax | 12.17%1.27M | 51.34%1.81M | -49.68%620K | 8.53%4.59M | 14.12%1.12M | -39.55%1.13M | 43.92%1.2M | 127.31%1.23M | -4.12%4.23M | -65.39%977K |
| Net income | -82.14%339K | 142.12%3.52M | -27.83%1.16M | 21.38%8.94M | 54.38%3.95M | 0.48%1.9M | 27.12%1.45M | -9.57%1.61M | -18.13%7.37M | -8.75%2.56M |
| Net income continuous operations | -82.14%339K | 142.12%3.52M | -27.83%1.16M | 21.38%8.94M | 54.38%3.95M | 0.48%1.9M | 27.12%1.45M | -9.57%1.61M | -18.13%7.37M | -8.75%2.56M |
| Noncontrolling interests | -2,450.00%-51K | 50.00%-2K | -1,800.00%-76K | -421.98%-122.83K | -1,342.86%-101K | 66.67%-2K | 50.00%-4K | 50.00%-4K | -4.61%-23.53K | -100.29%-7K |
| Net income attributable to the company | -79.47%390K | 141.59%3.52M | -23.29%1.24M | 22.66%9.06M | 57.89%4.05M | 0.26%1.9M | 26.59%1.46M | -9.75%1.61M | -18.07%7.39M | -8.61%2.57M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -79.47%390K | 141.59%3.52M | -23.29%1.24M | 22.66%9.06M | 57.89%4.05M | 0.26%1.9M | 26.59%1.46M | -9.75%1.61M | -18.07%7.39M | -8.61%2.57M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -79.31%0.0054 | 142.00%0.0484 | -23.08%0.017 | 22.66%0.1245 | 57.95%0.0556 | 0.38%0.0261 | 26.58%0.02 | -9.80%0.0221 | -18.08%0.1015 | -8.57%0.0352 |
| Diluted earnings per share | -79.31%0.0054 | 142.00%0.0484 | -23.08%0.017 | 22.66%0.1245 | 57.95%0.0556 | 0.38%0.0261 | 26.58%0.02 | -9.80%0.0221 | -18.08%0.1015 | -8.57%0.0352 |
| Dividend per share | 0 | -20.00%0.04 | 0 | 100.00%0.05 | 0 | 0 | 100.00%0.05 | 0 | -26.47%0.025 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.